ALNY
USDAlnylam Pharmaceuticals Inc. Common Stock
$423.470-6.530 (-1.519%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$430.000
High
$431.500
Low
$421.830
Volume
0.92M
Company Fundamentals
Market Cap
55.9B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.16M
Exchange
NMS
Currency
USD
52-Week Range
Low $205.87Current $423.470High $495.55
Related News
Analyst Upgrades
Piper Sandler Reiterates Overweight on Alnylam Pharmaceuticals, Raises Price Target to $489
Piper Sandler analyst Edward Tenthoff reiterates Alnylam Pharmaceuticals with a Overweight and raises the price target from $449 to $489.
View more
Analyst Upgrades
Barclays Maintains Overweight on Alnylam Pharmaceuticals, Raises Price Target to $527
Barclays analyst Gena Wang maintains Alnylam Pharmaceuticals with a Overweight and raises the price target from $460 to $527.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.